Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01146509 · ClinicalTrials.gov registry record · Phase 2
An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis
A Phase 2 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 2
- Development phase
- 89
- Enrollment target
NCT01146509 is a Phase 2 study that has completed, run by Eisai. The registered enrollment target is 89 participants.
The verdict
NCT01146509, a Phase 2 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this extension study was to evaluate the safety and efficacy of donepezil hydrochloride after extended use in migraine prophylaxis. Efficacy will continue to be evaluated.
Interventions
- DRUG Aricept (donepezil hydrochloride)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2003-01 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01146509
The ClinicalTrials.gov registry entry for NCT01146509 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aricept (donepezil hydrochloride) is the first listed.
NCT01146509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01146509 about?
NCT01146509 is a clinical study titled "An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis". The purpose of this extension study was to evaluate the safety and efficacy of donepezil hydrochloride after extended use in migraine prophylaxis. Efficacy will continue to be evaluated.
What is the current status of trial NCT01146509?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2003-01. Estimated completion is 2007-03.
What interventions are being tested in trial NCT01146509?
The interventions under investigation include: Aricept (donepezil hydrochloride) (DRUG).
Who is sponsoring clinical trial NCT01146509?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.